Drug Patent Expirations for Jul 2, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

CLARINEX D 24 HOUR (desloratadine; pseudoephedrine sulfate)
Merck Sharp Dohme
Patent number: 7,214,684
Expiration Date: Jun 30, 2015


CLARINEX-D 12 HOUR (desloratadine; pseudoephedrine sulfate)
Merck Sharp Dohme
Patent number: 7,214,684
Expiration Date: Jun 30, 2015


CLARINEX (desloratadine)
Merck Sharp Dohme
Patent number: 7,214,684
Expiration Date: Jun 30, 2015


CLARINEX (desloratadine)
Merck Sharp Dohme
Patent number: 7,211,582
Expiration Date: Jun 30, 2015


CLARINEX D 24 HOUR (desloratadine; pseudoephedrine sulfate)
Merck Sharp Dohme
Patent number: 7,214,683
Expiration Date: Jun 30, 2015


CLARINEX-D 12 HOUR (desloratadine; pseudoephedrine sulfate)
Merck Sharp Dohme
Patent number: 7,214,683
Expiration Date: Jun 30, 2015


MYLOTARG (gemtuzumab ozogamicin)
Wyeth Pharms Inc
Patent number: 5,773,001
Expiration Date: Jun 30, 2015


CLARINEX (desloratadine)
Merck Sharp Dohme
Patent number: 7,214,683
Expiration Date: Jun 30, 2015


GLEEVEC (imatinib mesylate)
Novartis
Patent number: 5,521,184
Expiration Date: Jul 4, 2015


For more information try a free trial

Click here for reuse options!
Copyright 2015 Biotechblog

Leave a Reply

%d bloggers like this: